denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: educational grants from AstraZeneca and Pharmacyclics.
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Biological, antibodies, anticoagulant drugs, therapy sequence, Adult, survivorship, Diseases, CLL, Lymphoma (any), Non-Biological, drug-drug interaction, Therapies, CAR-Ts, Combinations, biopsy, Elderly, chemotherapy, Adverse Events, coagulant drugs, Biological Processes, gene therapy, Technology and Procedures, immunotherapy, epigenetics, Cell Lineage, Lymphoid Malignancies, infusion, Study Population, genomics, Clinically relevant, Quality Improvement , transplantation, immune mechanism, flow cytometry, TKI, molecular testing, microenvironment, pathogenesis, signal transduction
Hematology Disease Topics & Pathways:
Biological, antibodies, anticoagulant drugs, therapy sequence, Adult, survivorship, Diseases, CLL, Lymphoma (any), Non-Biological, drug-drug interaction, Therapies, CAR-Ts, Combinations, biopsy, Elderly, chemotherapy, Adverse Events, coagulant drugs, Biological Processes, gene therapy, Technology and Procedures, immunotherapy, epigenetics, Cell Lineage, Lymphoid Malignancies, infusion, Study Population, genomics, Clinically relevant, Quality Improvement , transplantation, immune mechanism, flow cytometry, TKI, molecular testing, microenvironment, pathogenesis, signal transduction
Friday, December 4, 2020: 3:00 PM-6:00 PM
Chair:
Richard R. Furman, MD, Weill Cornell Medical College
Disclosures:
Furman: Abbvie: Consultancy; Acerta: Consultancy; AstraZeneca: Consultancy, Research Funding; Beigene: Consultancy; Genentech: Consultancy; Incyte: Consultancy; Janssen: Consultancy, Speakers Bureau; Loxo Oncology: Consultancy; Oncotarget: Consultancy; Pharmacyclics: Consultancy; Sunesis: Consultancy; TG Therapeutics: Consultancy, Research Funding; Verastem: Consultancy.
Speakers:
Farrukh T Awan, MD, UT Southwestern, University of Texas Southwestern Medical Center
,
Steven Coutre, MD, Stanford University School of Medicine
and
Asher Chanan-Khan, MBBS, MD, Professor of Medicine, Mayo Clinic
Disclosures:
Awan: Sunesis: Consultancy; Celgene: Consultancy; Blueprint medicines: Consultancy; MEI Pharma: Consultancy; Karyopharm: Consultancy; Dava Oncology: Consultancy; Kite Pharma: Consultancy; Gilead Sciences: Consultancy; Pharmacyclics: Consultancy; Janssen: Consultancy; Abbvie: Consultancy; Astrazeneca: Consultancy; Genentech: Consultancy.
How to Do It™ Interactive Workshop: Taking Action With Clinical Advances in Chronic Lymphocytic Leukemia, a CME-certified Friday Satellite symposium to be presented at the ASH Annual Meeting will feature a series of didactic followed by “How To Do It” interactive small group breakouts between learners and faculty. Using a blended instructional model of didactic presentations, interactive panel discussions and small group breakouts is intended is to improve medical practices and patient care through evidence-based presentations, discussion, and authoritative peer-exchange on important clinical issues.
- The activity is designed to highlight and test participants on the most clinically relevant data in CLL, provide expert guidance on the interpretation of core concepts, and forecast the clinical impact of recent data sets.
- To further enhance the integration of recent data into practice, the program will feature “How to Do It” group break outs, where presenting faculty and additional CLL faculty experts will join learners at their tables to share their own practice preferences (“How I treat”), perspectives on the clinical trial data and share clinical pearls from their own practices. Learners will have the opportunity to share cases for review with the faculty and other learners.
See more of: Satellite Symposia